RE: 3 MTH Agreement extension15 Aug 2020 16:35
Nice Chad and Applegarth and holders of all size. Many of my friends have small positions, am equally happy at the prospects of helping them with future house deposits. £1k has the potential to be life changing over 5 to 10 year timescale.
With regards to Eli Lilly deal extending into sep or December. That's not the deal, if Lily don't sign by end of Aug Hemo have the right to negotiate financial terms for Eli Lillys contribution and can then offer to broader market.
IMO would kill the SP in September and we'd be at the will of other Pharmas seeing value in CDX. With the unveiling of Eli Lilly name this scenario seems an outsider.
As side note in Jan 2019 Eli Lilly said they weren't interested in CAR-T acquisitions over cost of individual treatments $400,000 and concerns over blood conditioning and risk of cytokine storms.
I'm no Dr so don't take my word and do own research. It's my understanding one of Hemo's developments is switch to turn off the CAR-T response to avoid a storm. Also read a tweet by Vlad about unnamed developments trying to bring down the cost of CAR-T cell treatment. Could be a Vlad hint, could be a reference to others science.
We'll know the answer on CDX long before CAR-T. 1st sep 12 working days.....